Mandate

Vinge advises VEF Ltd in relation to the group’s change of domicile from Bermuda to Sweden

Vinge has advised VNV Ltd in connection with the process of changing the group’s domicile from Bermuda to Sweden (the “Redomestication”). The Redomestication is carried out by way of a scheme of arrangement under Bermuda law, whereby Swedish Depository Receipts in VEF Ltd are exchanged for shares in the Swedish group entity VEF AB (publ), which constitutes the new parent company of the group following the Redomestication. The shares of VEF AB (publ) is listed on Nasdaq First North Premier Growth Market.

VEF Ltd is an investment company that invests in growth stage private fintech companies. VEF focuses on scale emerging markets and invests across all areas of financial services inclusive of payments, credit, mobile money and wealth advisors.

Vinge’s team consisted of Jesper Schönbeck, Joel Wahlberg, Martin Boström and Anna Svensson (Capital Markets & Public M&A) and Maria Schultzberg (tax).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026